AlzChem Group AG (ACT.DE) Comparison with companies in other sectors?

AlzChem Group AG has a share price of 10.15M. You can analyze AlzChem Group AG (ACT.DE) competitors across different market sectors through stock heatmaps.

What are ACT.DE's NET and operating margins?

AlzChem Group AG (ACT.DE) operating margin is around 0.20, and net profit margin is approximately 0.10 as of the latest reports.

In what way does ACT.DE's earnings per share (EPS) trend reflect its financial momentum?

AlzChem Group AG (ACT.DE) EPS is 5.56 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for AlzChem Group AG is 26.80, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for AlzChem Group AG?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for AlzChem Group AG like P/E which is 27.00, P/B which is 6.90, and PEG which is 5.98. Compare them with sector averages to evaluate if the stock is priced fairly.

AlzChem Group AG

ACT.DE•XETRA

Basic Materials

Chemicals - Specialty

€154.60

€19.40(14.35%)

AlzChem Group AG (ACT.DE) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$5.56

P/E Ratio

26.80

ROE

0.28%

Net Margin

0.10%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$1.51B

Shares OutstandingTotal number of shares issued

$10.15M

Book Value/ShareNet worth per share

$22.05

Revenue/ShareAnnual revenue per share

$54.10

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$5.56

Net MarginNet income as percentage of revenue

10.32%

Operating MarginOperating income as percentage of revenue

19.93%

ROEReturn on shareholders' equity

28.25%

ROAReturn on total assets

10.15%

ROCEReturn on capital employed

24.86%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$7.18

Cash/ShareCash and equivalents per share

$9.04

FCF YieldFree cash flow as percentage of market cap

4.75%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$1.80

Dividend YieldAnnual dividend as percentage of stock price

1.20%

Financial Ratios Analysis data is not available for ACT.DEFinancial Ratios Analysis details for ACT.DE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for ACT.DESector Benchmarking details for ACT.DE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for AlzChem Group AG Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of AlzChem Group AG. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account AlzChem Group AG's unique business strengths and challenges.

Key Financial Metrics for AlzChem Group AG

For AlzChem Group AG, essential financial indicators include EPS 5.56, PE 26.80, and ROE 0.28. These key ratios reveal insights into AlzChem Group AG's profitability, valuation, and operational health. Understanding these metrics enables you to compare AlzChem Group AG with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of AlzChem Group AG

Metrics like Net Margin 10.32% and ROA 10.15% shed light on how well AlzChem Group AG is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether AlzChem Group AG can sustain its operations and continue growing in the future.

Valuation and Market Position of AlzChem Group AG

Using ratios such as P/B Ratio 6.90 and PEG Ratio 5.98, investors can assess whether AlzChem Group AG is appropriately valued based on its financials and growth potential. These figures, combined with AlzChem Group AG's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for AlzChem Group AG

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow $7.18, provide a snapshot of AlzChem Group AG's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like AlzChem Group AG, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for AlzChem Group AG

Investing in AlzChem Group AG based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at AlzChem Group AG focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;